These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 23496350)

  • 1. Improved intensive care unit survival for critically ill allogeneic haematopoietic stem cell transplant recipients following reduced intensity conditioning.
    Townsend WM; Holroyd A; Pearce R; Mackinnon S; Naik P; Goldstone AH; Linch DC; Peggs KS; Thomson KJ; Singer M; Howell DC; Morris EC
    Br J Haematol; 2013 May; 161(4):578-86. PubMed ID: 23496350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic factors for patients with hematologic malignancies admitted to the intensive care unit: is allogeneic transplantation still a risk factor?
    Wu PH; Huo WX; Mo XD; Wang Y; Yan CH; Jiang H; Shen MZ; Huang XJ; An YZ
    Ann Hematol; 2023 Apr; 102(4):907-916. PubMed ID: 36757444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes and Long-Term Survival of Adolescent and Young Adult Patients Admitted to the Intensive Care Unit Following Allogeneic Hematopoietic Stem Cell Transplantation: A Single-Center Experience of 152 Patients.
    Solaiman OM; Elhassan T; Fakih RE; Mannan A; Alduhailib Z; Mahdali AA; Alzahrani H; Jamil M; Chaudhri N; Elhazmi A; Kolko M; Al-Sharif FZ; Alrbiaan A; Shaban M; Shaheen M; Salahuddin N; Alfraih FA; Altarifi AS; Hassanein M; Hosaini S; Alhashim N; Mohamed AA; Hanbali A; Aljanoubi AH; Al-Obaidi NR; Rasheed W; Maghrabi K; Almohareb F; Soubani A; Aljurf M; Ahmed SO
    Hematol Oncol Stem Cell Ther; 2024 Mar; 17(2):110-119. PubMed ID: 38560973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allogeneic hematopoietic stem cell transplantation after reduced intensity conditioning regimen: Outcomes of patients admitted to intensive care unit.
    Mokart D; Granata A; Crocchiolo R; Sannini A; Chow-Chine L; Brun JP; Bisbal M; Faucher M; Faucher C; Blache JL; Castagna L; Fürst S; Blaise D
    J Crit Care; 2015 Oct; 30(5):1107-13. PubMed ID: 26193780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical outcomes in allogeneic haematopoietic stem cell transplantation: A comparison between young and elderly patients. Observational study.
    Chapchap EC; Kerbauy LN; Esteves I; Belucci TR; Rodrigues M; Kerbauy FR; de Souza Santos FP; Ribeiro AAF; Hamerschlak N
    Eur J Cancer Care (Engl); 2019 Sep; 28(5):e13122. PubMed ID: 31257689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved short- and long-term outcome of allogeneic stem cell recipients admitted to the intensive care unit: a retrospective longitudinal analysis of 942 patients.
    Lueck C; Stadler M; Koenecke C; Hoeper MM; Dammann E; Schneider A; Kielstein JT; Ganser A; Eder M; Beutel G
    Intensive Care Med; 2018 Sep; 44(9):1483-1492. PubMed ID: 30141173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognosis of Allogeneic Haematopoietic Stem Cell Recipients Admitted to the Intensive Care Unit: A Retrospective, Single-Centre Study.
    Lindgaard SC; Nielsen J; Lindmark A; Sengeløv H
    Acta Haematol; 2016; 135(2):72-8. PubMed ID: 26512978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome of critically ill allogeneic hematopoietic stem-cell transplantation recipients: a reappraisal of indications for organ failure supports.
    Pène F; Aubron C; Azoulay E; Blot F; Thiéry G; Raynard B; Schlemmer B; Nitenberg G; Buzyn A; Arnaud P; Socié G; Mira JP
    J Clin Oncol; 2006 Feb; 24(4):643-9. PubMed ID: 16380411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Admission of hematopoietic cell transplantation patients to the intensive care unit at the Pontificia Universidad Católica de Chile Hospital.
    Escobar K; Rojas P; Ernst D; Bertin P; Nervi B; Jara V; Garcia MJ; Ocqueteau M; Sarmiento M; Ramirez P
    Biol Blood Marrow Transplant; 2015 Jan; 21(1):176-9. PubMed ID: 25139214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of patients with haematological malignancies admitted to intensive care unit. A comparative review of allogeneic haematopoietic stem cell transplantation data.
    Lim Z; Pagliuca A; Simpson S; Cottam S; Ervine M; Ho AY; Devereux S; Mufti GJ
    Br J Haematol; 2007 Feb; 136(3):448-50. PubMed ID: 17156405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequential Organ Failure Assessment Score and the Need for Organ Support Predict Mortality in Allogeneic Stem Cell Transplant Patients Admitted to the Intensive Care Unit.
    Díaz-Lagares C; Fox L; García-Roche A; Santafe M; Romera I; Barba P; Pacheco A; Roldán E; Plata-Menchaca E; Roca O; Pérez M; Valcarcel D; Ferrer R
    Transplant Cell Ther; 2021 Oct; 27(10):865.e1-865.e7. PubMed ID: 34217846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epileptic seizures in patients following allogeneic hematopoietic stem cell transplantation: a retrospective analysis of incidence, risk factors, and survival rates.
    Zhang XH; Xu LP; Liu DH; Chen H; Han W; Chen YH; Wang FR; Wang JZ; Wang Y; Zhao T; Chen Y; Fu HX; Liu KY; Huang XJ
    Clin Transplant; 2013; 27(1):80-9. PubMed ID: 22938074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of outcomes after two standards-of-care reduced-intensity conditioning regimens and two different graft sources for allogeneic stem cell transplantation in adults with hematologic diseases: a single-center analysis.
    Le Bourgeois A; Mohr C; Guillaume T; Delaunay J; Malard F; Loirat M; Peterlin P; Blin N; Dubruille V; Mahe B; Gastinne T; Le Gouill S; Moreau P; Mohty M; Planche L; Lode L; Bene MC; Chevallier P
    Biol Blood Marrow Transplant; 2013 Jun; 19(6):934-9. PubMed ID: 23523970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of factors associated with survival in allogeneic stem cell-transplanted patients admitted to the intensive care unit (ICU).
    Serries M; Zenzen H; Heine M; Holderried T; Brossart P; Schwab K
    Hematology; 2023 Dec; 28(1):2256198. PubMed ID: 37737158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Critically ill allogeneic hematopoietic stem cell transplantation patients in the intensive care unit: reappraisal of actual prognosis.
    Saillard C; Blaise D; Mokart D
    Bone Marrow Transplant; 2016 Aug; 51(8):1050-61. PubMed ID: 27042832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes and prognostic factors in patients with haematological malignancy admitted to a specialist cancer intensive care unit: a 5 yr study.
    Bird GT; Farquhar-Smith P; Wigmore T; Potter M; Gruber PC
    Br J Anaesth; 2012 Mar; 108(3):452-9. PubMed ID: 22298243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors associated with liver injury and impact of liver injury on transplantation-related mortality in pediatric recipients of allogeneic hematopoietic stem cell transplantation.
    Radhakrishnan K; Bishop J; Jin Z; Kothari K; Bhatia M; George D; Garvin JH; Martinez M; Ovchinsky N; Lobritto S; Elsayed Y; Satwani P
    Biol Blood Marrow Transplant; 2013 Jun; 19(6):912-7. PubMed ID: 23467127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Comparison of the Myeloablative Conditioning Regimen Fludarabine/Busulfan with Cyclophosphamide/Total Body Irradiation, for Allogeneic Stem Cell Transplantation in the Modern Era: A Cohort Analysis.
    Gooptu M; Kim HT; Ho VT; Alyea EP; Koreth J; Armand P; Ritz J; Nikiforow S; Glotzbecker BE; Nageshwar P; Soiffer RJ; Antin JH; Cutler CS
    Biol Blood Marrow Transplant; 2018 Aug; 24(8):1733-1740. PubMed ID: 29555313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced-intensity conditioning before allogeneic hematopoietic stem cell transplantation in patients over 60 years: a report from the SFGM-TC.
    Chevallier P; Szydlo RM; Blaise D; Tabrizi R; Michallet M; Uzunov M; Fegueux N; Guilhot F; Lapusan S; Gratecos N; Cahn JY; Socié G; Yakoub-Agha I; Huynh A; Francois S; Bay JO; Maury S; Buzyn A; Contentin N; Mohty M
    Biol Blood Marrow Transplant; 2012 Feb; 18(2):289-94. PubMed ID: 21781949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Introduction of the oncological pediatric risk of mortality score (O-PRISM) for ICU support following stem cell transplantation in children.
    Schneider DT; Lemburg P; Sprock I; Heying R; Göbel U; Nürnberger W
    Bone Marrow Transplant; 2000 May; 25(10):1079-86. PubMed ID: 10828869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.